PreOperative Performance Enters the SOPHIE Program to Fuel Collaboration with Ontario-Based Radiology Researchers

PreOperative Performance is a SOPHIE company partnering with The Research Institute of St. Joes Hamilton to to help neuroradiologists to assess the quality and consistency of MRI diffusion imaging protocols.

Through the SOPHIE program, PreOperative Performance will enter a 12-month co-development partnership with The Research Institute of St. Joe’s Hamilton (RSJH) to evaluate technology that aims to help radiology groups make better quality measurements of MRI machines. This press release was originally shared by PreOperative Performance through Newswire on June 14, 2023. Read the original […]

Fusion Pharmaceuticals Announces IND Clearance For FPI-2068, A Jointly Developed Novel Targeted Alpha Therapy

In the news: Fusion Pharmaceuticals. The background image is a woman researcher working in a lab while wearing personal protective equipment (PPE).

This press release was originally published by Fusion Pharmaceuticals on April 12, 2023. Read the original post here. FPI-2068 is a Bispecific Targeted Alpha Therapy (TAT) designed to Precisely Deliver Radiation to Tumor Cells HAMILTON, ON and BOSTON, April 12, 2023 /– Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision […]

McMaster researchers receive $61 million from CIHR to advance health research

A group photo of seven researchers, university president David Farrar, MP Filomena Tassi and CIHR president Strong.

This article was first published on Brighter World – McMaster University. Read the original article. Seven McMaster-led research projects have received a total of $61 million from the Canadian Institutes of Health Research (CIHR) to advance medical research, training and innovation. The announcement was made at McMaster by Filomena Tassi, MP for Hamilton West-Ancaster-Dundas and minister responsible […]

Our website uses cookies to ensure you get the best experience. Learn more about the policy